Maestro PMS, the industry’s trusted all-in-one hospitality management solution, today reveals its “2026 Software & Innovation ...

ClearPoint Neuro (NASDAQ:CLPT) announced the U.S. Food and Drug Administration (FDA) 510(k) clearance to its Maestro Brain Model, intended for automatic labeling, visualization, volumetric and shape ...

ClearPoint Neuro CLPT announced the U.S. Food and Drug Administration (FDA) 510(k) clearance to its Maestro Brain Model, intended for automatic labeling, visualization, volumetric and shape ...

The free Maestro software offers Java application developers tools for managing builds, mapping dependencies and tracking reusable chunks of code. Making its debut in May, Maestro is designed to ...

UiPath remains a buy, outperforming the S&P 500 with a 53.6% gain since March 2025, driven by operational turnaround. Click ...